Fruit juice inhibition of uptake transport: a new type of food-drug interaction
about
Grapefruit-medication interactions: forbidden fruit or avoidable consequences?Hospital Performance Indicators and Their Associated Factors in Acute Child Poisoning at a Single Poison Center, Central Saudi ArabiaThe mechanism of Naringin-enhanced remyelination after spinal cord injury.A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect"Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria.Fingerprinting food: current technologies for the detection of food adulteration and contamination.Influence of dietary substances on intestinal drug metabolism and transport.Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren.Treatment-refractory hypothyroidism.Severity scores and their associated factors among orally poisoned toddlers: a cross sectional single poison center studyComparative outcome analysis of home-initiated non-medical interventions among toddlers with orally ingested substances.Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP.Apple juice greatly reduces systemic exposure to atenololCritical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticariaGrapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjectsMass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters.Effects of Lemon and Seville Orange Juices on the Pharmacokinetic Properties of Sildenafil in Healthy Subjects.Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department.Safety and efficacy of bilastine: a new H(1)-antihistamine for the treatment of allergic rhinoconjunctivitis and urticaria.Role of transporters in drug interactions.Clinical pharmacology confounders in older adults.The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.Formulation approaches in mitigating toxicity of orally administrated drugs.Effect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis.Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence.Bilastine for the treatment of urticaria.Enzyme- and transporter-mediated beverage-drug interactions: An update on fruit juices and green tea.Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.Flavonoids as modulators of metabolic enzymes and drug transporters.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review.The inhibitory effects of five alkaloids on the substrate transport mediated through human organic anion and cation transporters.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.Expression of Organic Anion Transporting Polypeptide 1A2 in Red Blood Cells and Its Potential Impact on Antimalarial Therapy.Inhibitory Effects of Multiple-Dose Treatment with Baicalein on the Pharmacokinetics of Ciprofloxacin in Rats.Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.Coffee inhibition of CYP3A4 in vitro was not translated to a grapefruit-like pharmacokinetic interaction clinically.Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria.Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5.
P2860
Q24611177-C6BBA52D-26D6-4967-BD57-A106334BCA1DQ28817503-43287064-3368-4CB6-962D-528D20EACA67Q33588579-F3DECB4D-1824-4E62-9926-6F48EDCE075CQ33645582-B4BA4338-9F12-43CE-8F5F-D5AE713F1A86Q33857214-23A6F706-E132-48A6-A372-BDBB91571702Q34238984-BDF67914-4851-4012-98DF-244E3C1E2264Q34315897-E460FF0E-8520-4802-B643-D0F1B8F30405Q34553835-2427361F-9C41-482D-9044-447E4873A10EQ34976482-A3883A89-FCF0-462F-A89D-06E769B70783Q35739879-2312C145-8752-4C58-B3E2-1C1EE287A5C4Q35884795-9D5C740F-6CFB-4D58-9EAE-CEF92016B1F1Q36060775-BE66A42D-EFD4-435C-8A96-C280988C1842Q36110576-EBCC7410-CB69-4ABB-AE08-C01B8DC27E4FQ36562479-BAC5F5C5-5DA8-4FC7-AA43-B3BC1E41A938Q36833151-67928765-BBFF-4A94-A436-6175A8A26F4AQ36948119-58AA7A1A-96BE-4C96-B5A9-9B7CACA5F38BQ37207759-5A616C1F-D46A-4162-823A-D1477FC7C848Q37302713-7775B446-1B39-4353-8E27-DC7EFD0BDC3FQ37633928-05B93272-BA4E-44F7-B879-77462FB2CBA9Q37914886-E6C7820D-B670-4347-A99B-81DAA0367FE4Q37964577-E95BA481-7655-4DB8-AA04-97FEDEF38D5EQ38040127-F2A08514-FEE0-4662-B949-18FD10622D0CQ38071690-AB47840B-FF10-48FB-9F05-C0639554AFC9Q38073886-72AD4C28-073C-454B-8AEE-98A33CD2D07DQ38087565-0A0BFB7A-8303-4553-A462-FBCB19AD8AD6Q38106829-33C0318B-0094-4234-BAAF-120AAEBF2700Q38107004-D16FD08E-FD59-403F-BF05-B12439D264D9Q38533636-97B3BE06-A8F5-435B-8B40-1CBA555F91C6Q38574619-660F8689-E0E8-401D-8005-0A1811204B2AQ38717216-63A02271-31B8-4CC5-9E04-C3025DA4937CQ38888350-02B5A58B-865B-447C-A955-84FB6A49AF09Q38972568-B8554AA4-41B0-4B37-BC41-E921F0437EBFQ39017932-6401930B-A6E2-4CF4-9FDE-2853B7043ED7Q39031326-575E47D9-6097-46BD-B9A4-AF41A1D95058Q39509379-DB98F0CE-C76E-430D-8816-03DD4F1FC47DQ40526599-E0DAB320-A012-49FB-B14A-67DB33262B2EQ42178200-465A90F1-EA1E-4EEF-B1CD-BBE9FB0AD2D9Q42285697-1C79FC95-3258-4D22-9566-21D50F476A19Q43190363-A2DE711F-CBD3-471A-B42E-CD69CC0F3728Q45342443-F7C5E8D9-B36E-4CD7-ADF3-5E86AA41BA20
P2860
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@ast
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@en
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@nl
type
label
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@ast
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@en
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@nl
prefLabel
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@ast
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@en
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@nl
P2860
P3181
P1476
Fruit juice inhibition of uptake transport: a new type of food-drug interaction
@en
P2093
David G Bailey
P2860
P304
P3181
P356
10.1111/J.1365-2125.2010.03722.X
P407
P577
2010-11-01T00:00:00Z